May 05, 2023 (Friday)  – Hall A (Grand Ballroom 03)
(The timings mentioned are as per the Indian Standard Time – IST)
Time (IST) Topic Faculty
09:00 AM – 10:30 AM Session 1:
Dr Sanjeevan Sharma,
Dr Krishna Ratnam
09:00 AM – 09:30 AM HSCT in MPN and it’s allies Dr Tania Jain
09:30 AM – 10:00 AM HSCT for AML in the molecular era Dr Vikram Mathews
10:00 AM – 10:30 AM Debate:
Dr Ranjit Sahoo,
Dr Rishi Dhawan
10:30 AM – 11:00 AM Coffee Break
11:00 AM – 11:15 AM Inaugural Ceremony
11:15 AM – 01:15 PM Session 2:
Joint Session of ISBMT with EBMT, ASTCT & APBMT
Dr Amir Ali Hamidieh,
Dr Tapan Saikia,
Dr Anna Sureda,
Dr Uday R Popat
11:15 AM – 11:45 AM Unravelling Fanconi Anaemia Biology Dr Shaji RV
11:45 AM – 12:15 PM Individualised HSCT for Fanconi Anaemia Dr Parinda Mehta
12:15 PM – 12:45 PM Unravelling the DNA in marrow failure Dr Hideki Muramatsu
12:45 PM – 01:15 PM Inherited bone marrow failure syndromes Dr Carlo Dufour
01:15 PM – 02:00 PM Industry Lunch Symposium – Emcure
(Theme: Treosulfan Across the Ages)
01:15 PM – 01:20 PM Introduction Dr Sunil Bhat
01:20 PM – 01:30 PM Treosulfan in Children less than 2 years Dr Satya P Yadav
01:30 PM – 01:40 PM Treosulfan in patients with co-morbidity Dr Padmaja Lokireddy
01:40 PM – 01:50 PM Treosulfan in the elderly Dr Sameer Melinkeri
01:50 PM – 02:00 PM Panel discussion Moderator:
Dr Sunil Bhat
Dr Satya P Yadav,
Dr Padmaja Lokireddy,
Dr Sameer Melinkeri
02:00 PM – 03:30 PM Session 3:
Lymphoma/ Myeloma
Dr Ajay Sharma, Dr Arijit Nag
02:00 PM – 02:30 PM CAR-T in Myeloma Dr Dinesh Bhurani
02:30 PM – 03:00 PM Double Hit NHL:
CART- T Vs. Auto Transplant
Dr Anant Gokarn,
Dr Punit Jain
03:00 PM – 03:30 PM Debate:
Autologous HSCT vs. Check point inhibitors in relapsed Hodgkin’s Lymphoma
Dr Atul Sharma,
Dr Pankaj Malhotra
03:30 PM – 05:00 PM Session 4:
Paediatric Session
Dr Deenadayalan M,
Dr Anand Prakash
03:30 PM – 04:00 PM How I transplant SCID Dr Fouzia NA
04:00 PM – 04:30 PM How I transplant Fanconi anaemia Dr Carmem Bonfim
04:30 PM – 05:00 PM Debate:
PTCY versus TCR alpha beta for infants
Dr Prashant Hiwarkar,
Dr Satyendra Katewa
05:00 PM – 06:00 PM Poster Session Judges:

Dr Chandran Nair &
Dr Vimal Kumar,

Dr Santosh Kumar &
Dr Shweta Bansal,

Dr Ramasawamy NV &
Dr Deenadayalan M,

Dr Venkatesh Ekbote &
Dr Reetu Jain,

Dr Shivani Patel &
Dr Prashant Chhabra,

Dr Sanjeevan Sharma &
Dr Punit Jain,

Dr Pankaj Malhotra &
Dr Dhaarani Jayaraman

06:00 PM – 07:30 PM ISBMT Registry Meeting and AGM
07:45 PM – 08:30 PM Industry Symposium – Cipla
(Theme: Smart Solutions for Super Bugs)
07:45 PM – 07:50 PM Introduction Dr Mammen Chandy
07:50  PM – 08:00 PM The Spectrum of Multi Drug Resistant Bacterial Infections in HSCT in India Dr Sushil Selvarajan
08:00  PM – 08:10 PM EDTA and Biocide combination Dr Lingaraj Nayak
08:10  PM – 08:20 PM AVIBACTAM – The Augmenting Force Dr Ruchira Misra
08:20  PM – 08:30 PM Panel discussion Moderator:

Dr Mammen Chandy


Dr Sushil Selvarajan,
Dr Lingaraj Nayak,
Dr Ruchira Misra

08:30 PM onwards Dinner
May 06, 2023 (Saturday)
(The timings mentioned are as per the Indian Standard Time – IST)
Hall A (Grand Ballroom 03) Hall B (Studio 06)
Time (IST) Topic Faculty Time Topic Faculty
08:00 AM – 09:00 AM Meet The Experts
Aplastic Anaemia Dr Parinda Mehta,
Dr Carmem Bonfim,
Dr Intezar Mehdi,
Dr Manas Kalra
How I transplant a patient with ALL Dr Sameer Melinkeri,
Dr Jose Easow,
Dr Sanjeevan Sharma,
Dr Krishnarathnam Kannan
09:00 AM – 10:45 AM Session 5:
Cellular Therapy
Dr Alok Srivastava,
Dr Seema Bhatwadekar
09:00 AM – 09:20 AM CAR T in lymphoma Sharat Damodar
09:20 AM – 09:40 AM Gene therapy for SCID Gaurav Kharya
09:40 AM – 10:00 AM CMV specific CTL Uday Kulkarni
10:00 AM – 10:20 AM CAR T in ALL Sunil Bhat
10:20 AM – 10:45 AM Q&A
10:45 AM – 11:00 AM BREAK
11:00 AM – 11:45 AM Industry Symposium – Takeda Pharmaceuticals
(Theme: Bringing Hope in Relapsed Refractory Hodgkin’s Lymphoma Patients)
11:00 AM – 11:45 AM Industry Symposium – Pfizer
(Theme: Innovative Options for Relapsed Refractory ALL)
11:00 AM – 11:20 AM Role of Adcetris post 1st Salvage in Relapsed Refractory cHL Dr Sharat Damodar 11:00 AM – 11:15 AM Recent Advances in Therapy For Relapsed Refractory ALL Dr Hari Menon
11:20 AM – 11:45 AM Panel Discussion:
How to Optimize Treatment Outcomes in R/R HL – Case based approach
Dr Dinesh BhuraniPanelists:Dr Sameer Melinkeri,
Dr Ashish Dixit,
Dr Reetu Jain,
Dr Arijit Nag
11:15 AM – 11:45 AM Case Based Panel Discussion Moderator:

Dr Rayaz Ahmed


Dr Hari Menon,
Dr Sandip Shah,
Dr Ranjit Sahoo,
Dr Venkateswaran V S

11:45 AM – 01:30 PM Session 7 11:45 AM – 01:30 PM Session 6: Chairs:
Dr Hari Menon,
Dr Sandip Shah,
Dr Ponni Sivaprakasam,
Dr Mallikarjun Kalashetty
11:45 AM – 12:15 PM How to make our service seamless Moderator:
Mr Raghu Rajagopal
Dr Meera Achrekar,
Mr Prathip Kumar,
Dr Rasmi Palassery,
Ms Saranya Srinivasan
11:45 AM – 11:53 AM Randomized Controlled Trial of Pre-Transplant Zoledronate versus Observation for Prevention of Bone Loss in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (Abstract ID: 84) Urmimala Bhattacharjee
11:53 AM – 12:01 PM Real Word Experience Of Allogenic Stem Cell Transplant In Bone Marrow Failure: A Single Centre Experience (Abstract ID: 110) Shreya Gopal Agrawal
12:01 PM – 12:09 PM Effect of conditioning regimen in the overall survival of individuals undergoing Haploidentical Stem Cell Transplantation: A Retrospective study from a tertiary care hospital in South India (Abstract ID: 113) Gohul GJ
12:09 PM – 12:17 PM Experience of Haplo SCT using GIAC protocol from tertiary care centre in North India (Abstract ID: 109) Sravan Dubasi
12:15 PM – 12:35 PM Challenges in Apheresis Dr Lakshman V 12:17 PM – 12:25 PM Haploidentical Peripheral Blood Stem Cell Transplant with Fludarabine – Myeloablative Total Body Irradiation as Conditioning Regimen with Post-Transplant Cyclophosphamide – A Single Centre Experience (Abstract ID: 102) Pragadeesh Thamarai Selvan
12:25 PM – 12:33 PM Conditioning with Fludarabine-Melphalan has better outcomes in Allogeneic Hematopoietic stem cell transplantation (HSCT) for Acute Myeloid Leukemia (AML) (Abstract ID: 97) Rajat Pincha
12:35 PM – 12:55 PM Cryopreservation Dr Satyam Arora 12:33 PM – 12:41 PM Randomized Controlled Trial of Fructo-Oligosaccharides (FOS) versus Observation to Restore Gut Microbiome and Improve Outcomes in Allogeneic Hematopoietic Cell Transplantation (Abstract ID: 06) Deepesh Lad
12:41 PM – 12:49 PM Molecular Patterns of Resistance in Carbapenem Resistant Organisms detected in Stool Surveillance Cultures in patients undergoing Hematopoietic Cell Transplant (Abstract ID: 90) Koustubh Kuber Shekar
12:55 PM – 01:15 PM Quality in HSCT Dr Mammen Chandy 12:49 PM – 12:57 PM Risk factors for Transplant Associated Thrombotic Microangiopathy (TA-TMA) among patients with Philadelphia positive (Ph+) leukemias undergoing Allogeneic Stem Cell Transplant (ASCT) (Abstract ID: 81) Anant Gokarn
12:57 PM – 01:05 PM TCR alpha beta haploidentical hematopoietic stem cell transplantation in inborn errors of immunity and the role of CD34 boost in improving immune reconstitution and survival (Abstract ID: 69) Venkateswaran V S
01:05 PM – 01:13 PM Novel Pre Transplant Immunosuppression In children with Thalassemia Major undergoing Allogeneic Hematopoietic Stem Cell Transplant- a retrospective study from Tertiary Care Center In India (Abstract ID: 62) Shweta Pathak
01:15 PM – 01:30 PM Q&A 01:13 PM – 01:21 PM Ten-year follow up study of children with thalassaemia major post transplantation using treosulfan, thiotepa, fludarabine based conditioning regimen and its impact on growth and puberty (Abstract ID: 59) Kavitha Ganesan
01:30 PM – 01:45 PM Valedictory
01:45 PM Onwards Lunch and Departures